EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ultrasound-Enhanced Drug Delivery in Pediatric Neuro-Oncology: A New Therapeutic Strategy

Elora Weber iD, Christian A Smith, Cynthia Hawkins, Uri Tabori, Peter B Dirks, James T Rutka iD

Pharmaceutics · 07.05.2026 · 18 (5) · 576

DOI: 10.3390/pharmaceutics18050576 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 07.05.2026. Verfasst von Elora Weber und 5 weiteren Autor:innen. Beteiligte Einrichtung: Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Terry Fox Foundation, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric brain tumors are highly prevalent and remain one of the leading causes of cancer-related deaths in children. There are numerous different brain tumor types that are now well characterized by magnetic resonance imaging (MRI), patient clinical course, and neuropathological and molecular genetic alterations. One of the challenges with treating pediatric brain tumors with systemic chemotherapy is the inability of several chemotherapeutic agents to cross the blood–brain barrier (BBB), which serves as a protective mechanism for neuronal homeostasis. The BBB primarily comprises microvascular endothelial tight junctions. Controlling BBB permeability to allow for therapeutics to cross and combat brain tumors is now possible using MR-guided focused ultrasound (MRgFUS). In this approach, microbubbles are administered intravenously prior to MRgFUS BBB disruption at the targeted tumor site in the brain. In the presence of MRgFUS, the microbubbles in the brain capillaries oscillate and temporarily disrupt the BBB, enabling systemically administered chemotherapy drugs to cross at the targeted site. In this review, we provide evidence supporting the use of MRgFUS BBB disruption to treat brain tumors in animal models and in ongoing human clinical drug trials. We conclude with efforts to harness the potency of the immune system using MRgFUS against pediatric brain tumors.

Schlagwörter

Stichwörter der Autor:innen

blood-brain barrierfocused ultrasoundgliomamagnetic resonance imagingmedulloblastomatumor immune microenvironment

Autor:innen und Institutionen

  • Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5R 0A3, Canada.
  • Department of Pathology, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
  • Department of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
  • Department of Medical Biophysics, University of Toronto, Toronto, ON M5R 0A3, Canada.
  • Department of Neurosurgery, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.

ORCID-Profile: Elora Weber, James T Rutka

Förderung

  • CIHR
  • Terry Fox Foundation
  • Canadian Institutes of Health Research
  • Terry Fox Research Institute
  • Meagan Bebenek Foundation
  • Wiley Foundation
  • ChadTough Foundation

Zitieren

APA

Weber, E., Smith, C. A., Hawkins, C., Tabori, U., Dirks, P. B., & Rutka, J. T. (2026). Ultrasound-Enhanced Drug Delivery in Pediatric Neuro-Oncology: A New Therapeutic Strategy. Pharmaceutics, 18(5), 576. https://doi.org/10.3390/pharmaceutics18050576

Vancouver

Weber E, Smith CA, Hawkins C, Tabori U, Dirks PB, Rutka JT. Ultrasound-Enhanced Drug Delivery in Pediatric Neuro-Oncology: A New Therapeutic Strategy. Pharmaceutics. 2026;18(5):576. doi:10.3390/pharmaceutics18050576

BibTeX
@article{Weber2026,
  author = {Weber, Elora and Smith, Christian A and Hawkins, Cynthia and Tabori, Uri and Dirks, Peter B and Rutka, James T},
  title = {Ultrasound-Enhanced Drug Delivery in Pediatric Neuro-Oncology: A New Therapeutic Strategy},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {576},
  doi = {10.3390/pharmaceutics18050576}
}
Kostenlos starten →